

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.98025651 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.98025651 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.57327065 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.57327065 |
| 5 | coenzyme catabolic process (GO:0009109) | 5.61806470 |
| 6 | immunoglobulin mediated immune response (GO:0016064) | 5.54603369 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.49777569 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.95309658 |
| 9 | T-helper 1 type immune response (GO:0042088) | 4.86359730 |
| 10 | B cell receptor signaling pathway (GO:0050853) | 4.84684326 |
| 11 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.76488924 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.70722252 |
| 13 | cofactor catabolic process (GO:0051187) | 4.70517718 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.64297513 |
| 15 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.62841253 |
| 16 | glyoxylate metabolic process (GO:0046487) | 4.53534746 |
| 17 | bile acid biosynthetic process (GO:0006699) | 4.52890001 |
| 18 | B cell mediated immunity (GO:0019724) | 4.50747706 |
| 19 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.48718125 |
| 20 | cellular ketone body metabolic process (GO:0046950) | 4.48486145 |
| 21 | NIK/NF-kappaB signaling (GO:0038061) | 4.46253316 |
| 22 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.39637586 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 4.33886587 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.26777557 |
| 25 | detection of bacterium (GO:0016045) | 4.25788746 |
| 26 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.25750774 |
| 27 | indole-containing compound catabolic process (GO:0042436) | 4.18522790 |
| 28 | indolalkylamine catabolic process (GO:0046218) | 4.18522790 |
| 29 | tryptophan catabolic process (GO:0006569) | 4.18522790 |
| 30 | high-density lipoprotein particle remodeling (GO:0034375) | 4.17753970 |
| 31 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.16434568 |
| 32 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.16434568 |
| 33 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.16434568 |
| 34 | modulation by symbiont of host immune response (GO:0052553) | 4.16434568 |
| 35 | positive regulation by symbiont of host defense response (GO:0052509) | 4.16434568 |
| 36 | modulation by symbiont of host defense response (GO:0052031) | 4.16434568 |
| 37 | aldehyde catabolic process (GO:0046185) | 4.10782040 |
| 38 | cellular response to type I interferon (GO:0071357) | 4.09647575 |
| 39 | type I interferon signaling pathway (GO:0060337) | 4.09647575 |
| 40 | regulation of fibrinolysis (GO:0051917) | 4.09222937 |
| 41 | kynurenine metabolic process (GO:0070189) | 4.09068795 |
| 42 | negative regulation of fibrinolysis (GO:0051918) | 4.07731834 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.06233713 |
| 44 | response to type I interferon (GO:0034340) | 4.05835149 |
| 45 | positive regulation of humoral immune response (GO:0002922) | 4.04582170 |
| 46 | aromatic amino acid family metabolic process (GO:0009072) | 4.02287029 |
| 47 | myeloid dendritic cell differentiation (GO:0043011) | 4.00186509 |
| 48 | tryptophan metabolic process (GO:0006568) | 3.95981846 |
| 49 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.95148901 |
| 50 | detection of other organism (GO:0098543) | 3.94718662 |
| 51 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.92860101 |
| 52 | bile acid metabolic process (GO:0008206) | 3.90370143 |
| 53 | T cell migration (GO:0072678) | 3.90227608 |
| 54 | ketone body metabolic process (GO:1902224) | 3.88386092 |
| 55 | B cell homeostasis (GO:0001782) | 3.87799419 |
| 56 | positive regulation of B cell differentiation (GO:0045579) | 3.84431624 |
| 57 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.81909856 |
| 58 | myeloid dendritic cell activation (GO:0001773) | 3.81190564 |
| 59 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.80821067 |
| 60 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.80134360 |
| 61 | protein carboxylation (GO:0018214) | 3.72348283 |
| 62 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.72348283 |
| 63 | urea cycle (GO:0000050) | 3.71830882 |
| 64 | urea metabolic process (GO:0019627) | 3.71830882 |
| 65 | alpha-linolenic acid metabolic process (GO:0036109) | 3.70692640 |
| 66 | regulation of protein activation cascade (GO:2000257) | 3.67913401 |
| 67 | response to muramyl dipeptide (GO:0032495) | 3.67415244 |
| 68 | regulation of cholesterol esterification (GO:0010872) | 3.67040559 |
| 69 | alpha-amino acid catabolic process (GO:1901606) | 3.65522995 |
| 70 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.65093040 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 3.61577631 |
| 72 | cysteine metabolic process (GO:0006534) | 3.57481190 |
| 73 | positive regulation of interferon-alpha production (GO:0032727) | 3.55036780 |
| 74 | negative thymic T cell selection (GO:0045060) | 3.54267462 |
| 75 | B cell proliferation (GO:0042100) | 3.52507071 |
| 76 | response to peptidoglycan (GO:0032494) | 3.52336931 |
| 77 | macromolecular complex remodeling (GO:0034367) | 3.51029983 |
| 78 | plasma lipoprotein particle remodeling (GO:0034369) | 3.51029983 |
| 79 | protein-lipid complex remodeling (GO:0034368) | 3.51029983 |
| 80 | regulation of interferon-alpha production (GO:0032647) | 3.50319687 |
| 81 | cellular response to interferon-gamma (GO:0071346) | 3.50035801 |
| 82 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.49470208 |
| 83 | nitrogen cycle metabolic process (GO:0071941) | 3.48647941 |
| 84 | heme transport (GO:0015886) | 3.48587244 |
| 85 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.47605029 |
| 86 | complement activation, alternative pathway (GO:0006957) | 3.46835798 |
| 87 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.46096938 |
| 88 | positive regulation of B cell mediated immunity (GO:0002714) | 3.45878234 |
| 89 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.45878234 |
| 90 | regulation of gamma-delta T cell activation (GO:0046643) | 3.45381157 |
| 91 | cellular amino acid catabolic process (GO:0009063) | 3.43875032 |
| 92 | serine family amino acid catabolic process (GO:0009071) | 3.43840952 |
| 93 | fatty acid elongation (GO:0030497) | 3.43030564 |
| 94 | reverse cholesterol transport (GO:0043691) | 3.42440362 |
| 95 | response to protozoan (GO:0001562) | 3.42245002 |
| 96 | T cell lineage commitment (GO:0002360) | 3.38806537 |
| 97 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.38227015 |
| 98 | positive regulation of macrophage cytokine production (GO:0060907) | 3.38175184 |
| 99 | regulation of complement activation (GO:0030449) | 3.37117808 |
| 100 | opsonization (GO:0008228) | 3.35612720 |
| 101 | glutamate metabolic process (GO:0006536) | 3.35325208 |
| 102 | peroxisome fission (GO:0016559) | 3.33459986 |
| 103 | blood coagulation, intrinsic pathway (GO:0007597) | 3.33174909 |
| 104 | T cell costimulation (GO:0031295) | 3.32979464 |
| 105 | triglyceride homeostasis (GO:0070328) | 3.32044463 |
| 106 | acylglycerol homeostasis (GO:0055090) | 3.32044463 |
| 107 | imidazole-containing compound metabolic process (GO:0052803) | 3.31653586 |
| 108 | regulation of antigen processing and presentation (GO:0002577) | 3.31026146 |
| 109 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.29206813 |
| 110 | negative regulation of cell killing (GO:0031342) | 3.29206813 |
| 111 | regulation of triglyceride catabolic process (GO:0010896) | 3.29116462 |
| 112 | lymphocyte costimulation (GO:0031294) | 3.27981809 |
| 113 | plasma lipoprotein particle clearance (GO:0034381) | 3.27507938 |
| 114 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.27422146 |
| 115 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.26978037 |
| 116 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.26062606 |
| 117 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.24028333 |
| 118 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.23823505 |
| 119 | acetyl-CoA metabolic process (GO:0006084) | 3.23431334 |
| 120 | glycine metabolic process (GO:0006544) | 3.23089191 |
| 121 | cholesterol efflux (GO:0033344) | 3.22056484 |
| 122 | serine family amino acid biosynthetic process (GO:0009070) | 3.21245943 |
| 123 | defense response to protozoan (GO:0042832) | 3.20864324 |
| 124 | positive regulation of B cell proliferation (GO:0030890) | 3.20613018 |
| 125 | regulation of B cell proliferation (GO:0030888) | 3.19730695 |
| 126 | phospholipid efflux (GO:0033700) | 3.18345949 |
| 127 | negative T cell selection (GO:0043383) | 3.17749235 |
| 128 | bile acid and bile salt transport (GO:0015721) | 3.17528936 |
| 129 | detection of external biotic stimulus (GO:0098581) | 3.13918495 |
| 130 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.13158746 |
| 131 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.12607727 |
| 132 | positive thymic T cell selection (GO:0045059) | 3.12466955 |
| 133 | regulation of B cell differentiation (GO:0045577) | 3.12352680 |
| 134 | aspartate family amino acid catabolic process (GO:0009068) | 3.11288375 |
| 135 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.11118967 |
| 136 | lysine metabolic process (GO:0006553) | 3.09704513 |
| 137 | lysine catabolic process (GO:0006554) | 3.09704513 |
| 138 | activation of MAPKKK activity (GO:0000185) | 3.09089320 |
| 139 | indolalkylamine metabolic process (GO:0006586) | 3.08644291 |
| 140 | negative regulation of interleukin-12 production (GO:0032695) | 3.08293859 |
| 141 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.07659484 |
| 142 | regulation of B cell apoptotic process (GO:0002902) | 3.07468259 |
| 143 | germinal center formation (GO:0002467) | 3.06964766 |
| 144 | serine family amino acid metabolic process (GO:0009069) | 3.06107697 |
| 145 | respiratory electron transport chain (GO:0022904) | 3.05853711 |
| 146 | electron transport chain (GO:0022900) | 3.05517232 |
| 147 | mature B cell differentiation involved in immune response (GO:0002313) | 3.05054272 |
| 148 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.04910450 |
| 149 | ATP synthesis coupled proton transport (GO:0015986) | 3.04910450 |
| 150 | response to interferon-gamma (GO:0034341) | 3.04730128 |
| 151 | negative regulation of sterol transport (GO:0032372) | 3.04459264 |
| 152 | negative regulation of cholesterol transport (GO:0032375) | 3.04459264 |
| 153 | positive regulation of antigen processing and presentation (GO:0002579) | 3.03957388 |
| 154 | macrophage activation involved in immune response (GO:0002281) | 3.03277428 |
| 155 | short-chain fatty acid metabolic process (GO:0046459) | 3.02603620 |
| 156 | organic acid catabolic process (GO:0016054) | 3.01875244 |
| 157 | carboxylic acid catabolic process (GO:0046395) | 3.01875244 |
| 158 | positive regulation of B cell activation (GO:0050871) | 3.01309670 |
| 159 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.01133145 |
| 160 | amino-acid betaine metabolic process (GO:0006577) | 3.00518564 |
| 161 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.99657141 |
| 162 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.98975196 |
| 163 | very long-chain fatty acid metabolic process (GO:0000038) | 2.97943501 |
| 164 | homocysteine metabolic process (GO:0050667) | 2.97093060 |
| 165 | dicarboxylic acid catabolic process (GO:0043649) | 2.96593816 |
| 166 | low-density lipoprotein particle remodeling (GO:0034374) | 2.95336803 |
| 167 | cellular biogenic amine catabolic process (GO:0042402) | 2.93859787 |
| 168 | amine catabolic process (GO:0009310) | 2.93859787 |
| 169 | L-serine metabolic process (GO:0006563) | 2.93736003 |
| 170 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.93246650 |
| 171 | response to host immune response (GO:0052572) | 2.93246650 |
| 172 | dendritic cell differentiation (GO:0097028) | 2.92925595 |
| 173 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.92591946 |
| 174 | acyl-CoA metabolic process (GO:0006637) | 2.92222284 |
| 175 | thioester metabolic process (GO:0035383) | 2.92222284 |
| 176 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.91909421 |
| 177 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.91782403 |
| 178 | negative regulation of B cell proliferation (GO:0030889) | 2.90506844 |
| 179 | arginine metabolic process (GO:0006525) | 2.88840644 |
| 180 | NAD biosynthetic process (GO:0009435) | 2.88380403 |
| 181 | regulation of B cell mediated immunity (GO:0002712) | 2.87223565 |
| 182 | phenol-containing compound catabolic process (GO:0019336) | 2.85695742 |
| 183 | thymic T cell selection (GO:0045061) | 2.85527960 |
| 184 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.84777460 |
| 185 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.84585464 |
| 186 | benzene-containing compound metabolic process (GO:0042537) | 2.84073234 |
| 187 | nucleobase catabolic process (GO:0046113) | 2.83784638 |
| 188 | negative regulation of lipase activity (GO:0060192) | 2.83322580 |
| 189 | negative regulation of protein activation cascade (GO:2000258) | 2.83041486 |
| 190 | mature B cell differentiation (GO:0002335) | 2.82172288 |
| 191 | cholesterol biosynthetic process (GO:0006695) | 2.81611093 |
| 192 | alkaloid metabolic process (GO:0009820) | 2.80302789 |
| 193 | drug metabolic process (GO:0017144) | 2.77217848 |
| 194 | regulation of interleukin-12 production (GO:0032655) | 2.75864388 |
| 195 | positive regulation of interferon-gamma production (GO:0032729) | 2.72281694 |
| 196 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.71266921 |
| 197 | lymphocyte homeostasis (GO:0002260) | 2.70996035 |
| 198 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.69813486 |
| 199 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.69486413 |
| 200 | positive regulation of interleukin-12 production (GO:0032735) | 2.68562443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.20120132 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.63194406 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.18143690 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.51760798 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.48892884 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.22946183 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.09167490 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.08198869 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 4.01231894 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.74265838 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.53076357 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.41220504 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.30637938 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.28503719 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.26109811 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.16988031 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.15711222 |
| 18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.91208892 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.52964050 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.51895118 |
| 21 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.50150259 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.47892147 |
| 23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.46543447 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.45865276 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.44437321 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.43181901 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.34059850 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.27115292 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.26753657 |
| 30 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.23552762 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20913839 |
| 32 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.19533800 |
| 33 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.13436051 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.11200441 |
| 35 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.05445364 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.02020034 |
| 37 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.00296978 |
| 38 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.95358954 |
| 39 | MYB_26560356_Chip-Seq_TH2_Human | 1.93825181 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.92712869 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.89153528 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.87751191 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86247269 |
| 44 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.85875281 |
| 45 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.83246355 |
| 46 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.82131674 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.79018813 |
| 48 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.78985204 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75709968 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74959659 |
| 51 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.70469705 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69847310 |
| 53 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68927747 |
| 54 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.66802979 |
| 55 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.62075641 |
| 56 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.61224635 |
| 57 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.60341902 |
| 58 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59405170 |
| 59 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.59080607 |
| 60 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.58931745 |
| 61 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.56687606 |
| 62 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.56663898 |
| 63 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.54888493 |
| 64 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.54295722 |
| 65 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48752518 |
| 66 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.48564586 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.48161769 |
| 68 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44699447 |
| 69 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.41248655 |
| 70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39966987 |
| 71 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.39333571 |
| 72 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.39033015 |
| 73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35008020 |
| 74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.34063156 |
| 75 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.31926062 |
| 76 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.31083431 |
| 77 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.30569420 |
| 78 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.30465403 |
| 79 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.30087526 |
| 80 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.28890529 |
| 81 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28486236 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28039684 |
| 83 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.27491805 |
| 84 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.27052602 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26517197 |
| 86 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.26081264 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25738301 |
| 88 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.24978754 |
| 89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24130375 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22275252 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21723551 |
| 92 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.21615904 |
| 93 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.20443266 |
| 94 | SPI1_23127762_ChIP-Seq_K562_Human | 1.19372607 |
| 95 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17942154 |
| 96 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.16912973 |
| 97 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.16627363 |
| 98 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.14600510 |
| 99 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.13354666 |
| 100 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.13152296 |
| 101 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12156395 |
| 102 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.11810729 |
| 103 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.11267879 |
| 104 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.10238304 |
| 105 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.09424127 |
| 106 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.07368695 |
| 107 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.04288767 |
| 108 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.04237346 |
| 109 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.03415574 |
| 110 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.03311259 |
| 111 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.03258107 |
| 112 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.02390147 |
| 113 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02156490 |
| 114 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02141641 |
| 115 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01994969 |
| 116 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01285597 |
| 117 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00139232 |
| 118 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.99630343 |
| 119 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.99130500 |
| 120 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99125516 |
| 121 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.99112038 |
| 122 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98587765 |
| 123 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.97794401 |
| 124 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.97582445 |
| 125 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96933298 |
| 126 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96915444 |
| 127 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96355775 |
| 128 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94894540 |
| 129 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.94769955 |
| 130 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93913882 |
| 131 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.93553824 |
| 132 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.93513205 |
| 133 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.92901325 |
| 134 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.92602268 |
| 135 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.92535558 |
| 136 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.91999432 |
| 137 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.91780917 |
| 138 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.91233613 |
| 139 | P68_20966046_ChIP-Seq_HELA_Human | 0.90424589 |
| 140 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89838505 |
| 141 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.88669314 |
| 142 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88398666 |
| 143 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.87320041 |
| 144 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87113040 |
| 145 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.86839805 |
| 146 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.86094336 |
| 147 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.85487957 |
| 148 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.85080795 |
| 149 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.84111766 |
| 150 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.83710505 |
| 151 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.83162106 |
| 152 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.82827591 |
| 153 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.81930427 |
| 154 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81754758 |
| 155 | NCOR_22424771_ChIP-Seq_293T_Human | 0.81470959 |
| 156 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.80819345 |
| 157 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.80124029 |
| 158 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79899255 |
| 159 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.79769733 |
| 160 | P300_19829295_ChIP-Seq_ESCs_Human | 0.79245291 |
| 161 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.78560562 |
| 162 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.77445564 |
| 163 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.75624422 |
| 164 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.75340238 |
| 165 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.75079262 |
| 166 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.74793963 |
| 167 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.73452268 |
| 168 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.73260952 |
| 169 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.73195526 |
| 170 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.73002786 |
| 171 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.72417932 |
| 172 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.71392251 |
| 173 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.71186621 |
| 174 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.69279849 |
| 175 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.68827340 |
| 176 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.67783849 |
| 177 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.67708423 |
| 178 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.67234803 |
| 179 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.66399943 |
| 180 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.66264918 |
| 181 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.66264918 |
| 182 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.64998698 |
| 183 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.62242933 |
| 184 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61991472 |
| 185 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.61629722 |
| 186 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.60844166 |
| 187 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.60533718 |
| 188 | FUS_26573619_Chip-Seq_HEK293_Human | 0.60284408 |
| 189 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.60212459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.95904884 |
| 2 | MP0005360_urolithiasis | 5.27945477 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.04094818 |
| 4 | MP0005365_abnormal_bile_salt | 4.70115366 |
| 5 | MP0000685_abnormal_immune_system | 4.31856134 |
| 6 | MP0005671_abnormal_response_to | 4.19234539 |
| 7 | MP0001835_abnormal_antigen_presentation | 4.05775173 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 4.03984844 |
| 9 | MP0003303_peritoneal_inflammation | 4.03902950 |
| 10 | MP0001790_abnormal_immune_system | 3.84977748 |
| 11 | MP0005387_immune_system_phenotype | 3.84977748 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 3.72718785 |
| 13 | MP0001800_abnormal_humoral_immune | 3.48532761 |
| 14 | MP0005000_abnormal_immune_tolerance | 3.28947123 |
| 15 | MP0003436_decreased_susceptibility_to | 3.08327345 |
| 16 | MP0005083_abnormal_biliary_tract | 2.89009745 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.78841306 |
| 18 | MP0002723_abnormal_immune_serum | 2.76676535 |
| 19 | MP0009785_altered_susceptibility_to | 2.62348609 |
| 20 | MP0003195_calcinosis | 2.57921093 |
| 21 | MP0005025_abnormal_response_to | 2.57295169 |
| 22 | MP0003252_abnormal_bile_duct | 2.51853269 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.48905248 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.47661362 |
| 25 | MP0010329_abnormal_lipoprotein_level | 2.46115481 |
| 26 | MP0005645_abnormal_hypothalamus_physiol | 2.44677314 |
| 27 | MP0001819_abnormal_immune_cell | 2.43107641 |
| 28 | MP0003763_abnormal_thymus_physiology | 2.40580739 |
| 29 | MP0002419_abnormal_innate_immunity | 2.33646589 |
| 30 | MP0005332_abnormal_amino_acid | 2.29767401 |
| 31 | MP0009840_abnormal_foam_cell | 2.28213135 |
| 32 | MP0002822_catalepsy | 2.24147625 |
| 33 | MP0003880_abnormal_central_pattern | 2.21960591 |
| 34 | MP0002398_abnormal_bone_marrow | 2.21690963 |
| 35 | MP0000716_abnormal_immune_system | 2.07699542 |
| 36 | MP0003300_gastrointestinal_ulcer | 2.05310655 |
| 37 | MP0005310_abnormal_salivary_gland | 1.94255970 |
| 38 | MP0004270_analgesia | 1.90436184 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.84974021 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 1.84737528 |
| 41 | MP0002837_dystrophic_cardiac_calcinosis | 1.83810212 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.80081175 |
| 43 | MP0006276_abnormal_autonomic_nervous | 1.79578720 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.79496573 |
| 45 | MP0002429_abnormal_blood_cell | 1.75473782 |
| 46 | * MP0002118_abnormal_lipid_homeostasis | 1.72818592 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.71802287 |
| 48 | MP0003329_amyloid_beta_deposits | 1.71395666 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.67795448 |
| 50 | MP0006035_abnormal_mitochondrial_morpho | 1.67433569 |
| 51 | MP0002722_abnormal_immune_system | 1.65050364 |
| 52 | MP0001968_abnormal_touch/_nociception | 1.63863357 |
| 53 | MP0001529_abnormal_vocalization | 1.63272659 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.61257130 |
| 55 | MP0003868_abnormal_feces_composition | 1.60984190 |
| 56 | MP0001666_abnormal_nutrient_absorption | 1.60815615 |
| 57 | MP0002735_abnormal_chemical_nociception | 1.58088420 |
| 58 | MP0002166_altered_tumor_susceptibility | 1.57977522 |
| 59 | MP0002405_respiratory_system_inflammati | 1.56504289 |
| 60 | MP0009745_abnormal_behavioral_response | 1.56092984 |
| 61 | MP0003191_abnormal_cellular_cholesterol | 1.55544300 |
| 62 | MP0004859_abnormal_synaptic_plasticity | 1.55521690 |
| 63 | MP0002064_seizures | 1.52084260 |
| 64 | MP0003011_delayed_dark_adaptation | 1.49736020 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.49695489 |
| 66 | MP0001853_heart_inflammation | 1.49512433 |
| 67 | MP0002876_abnormal_thyroid_physiology | 1.47976807 |
| 68 | MP0003635_abnormal_synaptic_transmissio | 1.46789008 |
| 69 | MP0008469_abnormal_protein_level | 1.46132400 |
| 70 | MP0002272_abnormal_nervous_system | 1.46064405 |
| 71 | MP0002736_abnormal_nociception_after | 1.45669514 |
| 72 | MP0004947_skin_inflammation | 1.42694117 |
| 73 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.42541909 |
| 74 | MP0000609_abnormal_liver_physiology | 1.41090368 |
| 75 | MP0001905_abnormal_dopamine_level | 1.40845986 |
| 76 | MP0000604_amyloidosis | 1.35941760 |
| 77 | MP0002572_abnormal_emotion/affect_behav | 1.35129871 |
| 78 | MP0003172_abnormal_lysosome_physiology | 1.34604776 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 1.33097079 |
| 80 | MP0003724_increased_susceptibility_to | 1.32183432 |
| 81 | MP0006082_CNS_inflammation | 1.31906123 |
| 82 | MP0002063_abnormal_learning/memory/cond | 1.31514812 |
| 83 | MP0010386_abnormal_urinary_bladder | 1.30226994 |
| 84 | MP0004510_myositis | 1.30178598 |
| 85 | MP0002734_abnormal_mechanical_nocicepti | 1.29163540 |
| 86 | MP0001440_abnormal_grooming_behavior | 1.27509296 |
| 87 | MP0004142_abnormal_muscle_tone | 1.26270573 |
| 88 | MP0009379_abnormal_foot_pigmentation | 1.23649771 |
| 89 | * MP0005535_abnormal_body_temperature | 1.23509145 |
| 90 | MP0009278_abnormal_bone_marrow | 1.22638173 |
| 91 | MP0001545_abnormal_hematopoietic_system | 1.21938024 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 1.21938024 |
| 93 | MP0009764_decreased_sensitivity_to | 1.21860708 |
| 94 | MP0000703_abnormal_thymus_morphology | 1.21241296 |
| 95 | MP0002006_tumorigenesis | 1.21139059 |
| 96 | MP0001764_abnormal_homeostasis | 1.20561142 |
| 97 | MP0009697_abnormal_copulation | 1.15628708 |
| 98 | MP0001970_abnormal_pain_threshold | 1.15463305 |
| 99 | MP0002733_abnormal_thermal_nociception | 1.15365852 |
| 100 | MP0001533_abnormal_skeleton_physiology | 1.15318243 |
| 101 | MP0001873_stomach_inflammation | 1.14908120 |
| 102 | MP0003186_abnormal_redox_activity | 1.14710809 |
| 103 | MP0005451_abnormal_body_composition | 1.12994703 |
| 104 | MP0000920_abnormal_myelination | 1.12729980 |
| 105 | MP0004858_abnormal_nervous_system | 1.08592862 |
| 106 | MP0003075_altered_response_to | 1.05789540 |
| 107 | MP0002396_abnormal_hematopoietic_system | 1.05406392 |
| 108 | MP0008874_decreased_physiological_sensi | 1.04971048 |
| 109 | MP0008872_abnormal_physiological_respon | 1.03414673 |
| 110 | MP0004924_abnormal_behavior | 1.02961980 |
| 111 | MP0005386_behavior/neurological_phenoty | 1.02961980 |
| 112 | MP0001984_abnormal_olfaction | 1.01755601 |
| 113 | MP0004019_abnormal_vitamin_homeostasis | 1.01720381 |
| 114 | MP0000858_altered_metastatic_potential | 1.01396132 |
| 115 | * MP0002078_abnormal_glucose_homeostasis | 1.00921444 |
| 116 | MP0005636_abnormal_mineral_homeostasis | 0.99792268 |
| 117 | MP0002090_abnormal_vision | 0.99260384 |
| 118 | MP0004808_abnormal_hematopoietic_stem | 0.98931719 |
| 119 | MP0001486_abnormal_startle_reflex | 0.97966214 |
| 120 | MP0002019_abnormal_tumor_incidence | 0.97895431 |
| 121 | MP0009763_increased_sensitivity_to | 0.97688754 |
| 122 | MP0009046_muscle_twitch | 0.94226207 |
| 123 | MP0005646_abnormal_pituitary_gland | 0.94205468 |
| 124 | MP0002229_neurodegeneration | 0.93108077 |
| 125 | MP0005166_decreased_susceptibility_to | 0.92536843 |
| 126 | MP0008057_abnormal_DNA_replication | 0.91715980 |
| 127 | MP0002138_abnormal_hepatobiliary_system | 0.91383190 |
| 128 | MP0004043_abnormal_pH_regulation | 0.89077437 |
| 129 | MP0001501_abnormal_sleep_pattern | 0.88494070 |
| 130 | MP0000343_altered_response_to | 0.85632343 |
| 131 | MP0000490_abnormal_crypts_of | 0.84327353 |
| 132 | MP0002067_abnormal_sensory_capabilities | 0.83591174 |
| 133 | MP0010094_abnormal_chromosome_stability | 0.81695395 |
| 134 | MP0001727_abnormal_embryo_implantation | 0.81489595 |
| 135 | MP0005266_abnormal_metabolism | 0.81246229 |
| 136 | MP0002998_abnormal_bone_remodeling | 0.80419597 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.80202748 |
| 138 | MP0009643_abnormal_urine_homeostasis | 0.78979590 |
| 139 | MP0001348_abnormal_lacrimal_gland | 0.76761801 |
| 140 | MP0002909_abnormal_adrenal_gland | 0.76026654 |
| 141 | MP0003866_abnormal_defecation | 0.75690454 |
| 142 | MP0009765_abnormal_xenobiotic_induced | 0.75466317 |
| 143 | MP0001663_abnormal_digestive_system | 0.75385000 |
| 144 | MP0002132_abnormal_respiratory_system | 0.75291483 |
| 145 | MP0003633_abnormal_nervous_system | 0.74670371 |
| 146 | MP0003091_abnormal_cell_migration | 0.74439248 |
| 147 | MP0003183_abnormal_peptide_metabolism | 0.73858503 |
| 148 | MP0005448_abnormal_energy_balance | 0.72491962 |
| 149 | MP0003111_abnormal_nucleus_morphology | 0.70920646 |
| 150 | MP0002184_abnormal_innervation | 0.70366356 |
| 151 | MP0002066_abnormal_motor_capabilities/c | 0.69435915 |
| 152 | MP0005551_abnormal_eye_electrophysiolog | 0.69253548 |
| 153 | MP0005220_abnormal_exocrine_pancreas | 0.69195568 |
| 154 | MP0000955_abnormal_spinal_cord | 0.68939372 |
| 155 | MP0003631_nervous_system_phenotype | 0.68593876 |
| 156 | MP0003690_abnormal_glial_cell | 0.67717902 |
| 157 | * MP0009642_abnormal_blood_homeostasis | 0.67653735 |
| 158 | MP0005075_abnormal_melanosome_morpholog | 0.66873141 |
| 159 | MP0002751_abnormal_autonomic_nervous | 0.66507471 |
| 160 | MP0005408_hypopigmentation | 0.66198576 |
| 161 | MP0003077_abnormal_cell_cycle | 0.64786547 |
| 162 | MP0008873_increased_physiological_sensi | 0.63892834 |
| 163 | MP0005084_abnormal_gallbladder_morpholo | 0.63568778 |
| 164 | MP0000313_abnormal_cell_death | 0.63419444 |
| 165 | MP0002069_abnormal_eating/drinking_beha | 0.63156896 |
| 166 | MP0003045_fibrosis | 0.63026605 |
| 167 | MP0003632_abnormal_nervous_system | 0.62818981 |
| 168 | MP0008260_abnormal_autophagy | 0.62807907 |
| 169 | MP0005379_endocrine/exocrine_gland_phen | 0.62084788 |
| 170 | * MP0003953_abnormal_hormone_level | 0.60916299 |
| 171 | MP0000249_abnormal_blood_vessel | 0.60100084 |
| 172 | MP0000465_gastrointestinal_hemorrhage | 0.59740348 |
| 173 | MP0002136_abnormal_kidney_physiology | 0.59495941 |
| 174 | MP0002933_joint_inflammation | 0.56853122 |
| 175 | MP0001851_eye_inflammation | 0.55832566 |
| 176 | MP0002163_abnormal_gland_morphology | 0.54905084 |
| 177 | MP0002693_abnormal_pancreas_physiology | 0.54279035 |
| 178 | MP0000371_diluted_coat_color | 0.53982237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gastrointestinal stroma tumor (HP:0100723) | 7.06201656 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.62557606 |
| 3 | Agammaglobulinemia (HP:0004432) | 5.89101721 |
| 4 | Recurrent sinusitis (HP:0011108) | 5.32010486 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 4.99491492 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 4.90822299 |
| 7 | IgA deficiency (HP:0002720) | 4.85430216 |
| 8 | Meningitis (HP:0001287) | 4.81628363 |
| 9 | Deep venous thrombosis (HP:0002625) | 4.61633429 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.31911677 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 4.31119855 |
| 12 | IgM deficiency (HP:0002850) | 4.30497787 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.29813352 |
| 14 | Cellulitis (HP:0100658) | 4.24432161 |
| 15 | Lymphopenia (HP:0001888) | 4.17254900 |
| 16 | Vasculitis (HP:0002633) | 4.16320502 |
| 17 | Eczematoid dermatitis (HP:0000976) | 4.12772986 |
| 18 | Recurrent bronchitis (HP:0002837) | 4.12485540 |
| 19 | Xanthomatosis (HP:0000991) | 4.11984125 |
| 20 | Recurrent viral infections (HP:0004429) | 4.04459399 |
| 21 | Emphysema (HP:0002097) | 3.91281509 |
| 22 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.89776450 |
| 23 | Colitis (HP:0002583) | 3.87268746 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 3.76922431 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.76238400 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.74988062 |
| 27 | Hyperventilation (HP:0002883) | 3.67260136 |
| 28 | Hyperlipoproteinemia (HP:0010980) | 3.61112366 |
| 29 | Recurrent pneumonia (HP:0006532) | 3.60899616 |
| 30 | Recurrent lower respiratory tract infections (HP:0002783) | 3.60541968 |
| 31 | Ketosis (HP:0001946) | 3.57470361 |
| 32 | Cerebral edema (HP:0002181) | 3.56753177 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.51675724 |
| 34 | Acute encephalopathy (HP:0006846) | 3.51020429 |
| 35 | Recurrent abscess formation (HP:0002722) | 3.50528014 |
| 36 | Panhypogammaglobulinemia (HP:0003139) | 3.48573682 |
| 37 | Acute necrotizing encephalopathy (HP:0006965) | 3.46681978 |
| 38 | Recurrent fungal infections (HP:0002841) | 3.40957698 |
| 39 | Increased serum pyruvate (HP:0003542) | 3.30695993 |
| 40 | Abnormality of glycolysis (HP:0004366) | 3.30695993 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 3.29144024 |
| 42 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.29144024 |
| 43 | Restrictive lung disease (HP:0002091) | 3.28140239 |
| 44 | Myokymia (HP:0002411) | 3.27120669 |
| 45 | Urticaria (HP:0001025) | 3.26367484 |
| 46 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.24530727 |
| 47 | Hepatic necrosis (HP:0002605) | 3.11074716 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 3.10944276 |
| 49 | Hyperglycinemia (HP:0002154) | 3.10609353 |
| 50 | Hepatocellular necrosis (HP:0001404) | 3.09907721 |
| 51 | Conjugated hyperbilirubinemia (HP:0002908) | 3.06645939 |
| 52 | Inflammation of the large intestine (HP:0002037) | 3.04780771 |
| 53 | Increased IgE level (HP:0003212) | 3.01666903 |
| 54 | Chronic obstructive pulmonary disease (HP:0006510) | 3.01512638 |
| 55 | Obstructive lung disease (HP:0006536) | 3.01512638 |
| 56 | IgG deficiency (HP:0004315) | 3.00941669 |
| 57 | Gastrointestinal inflammation (HP:0004386) | 2.99318049 |
| 58 | Ketoacidosis (HP:0001993) | 2.98676798 |
| 59 | Abnormality of T cell physiology (HP:0011840) | 2.97921320 |
| 60 | Hyperammonemia (HP:0001987) | 2.97578464 |
| 61 | Osteomyelitis (HP:0002754) | 2.97046446 |
| 62 | Recurrent skin infections (HP:0001581) | 2.96489240 |
| 63 | Chronic diarrhea (HP:0002028) | 2.95341494 |
| 64 | Abnormality of methionine metabolism (HP:0010901) | 2.94906673 |
| 65 | Mitochondrial inheritance (HP:0001427) | 2.94687790 |
| 66 | Hypolipoproteinemia (HP:0010981) | 2.89463811 |
| 67 | Joint hemorrhage (HP:0005261) | 2.86840415 |
| 68 | Abnormal gallbladder physiology (HP:0012438) | 2.84826072 |
| 69 | Cholecystitis (HP:0001082) | 2.84826072 |
| 70 | Complement deficiency (HP:0004431) | 2.84560659 |
| 71 | Progressive macrocephaly (HP:0004481) | 2.83764487 |
| 72 | Renal Fanconi syndrome (HP:0001994) | 2.79021840 |
| 73 | Increased IgM level (HP:0003496) | 2.78981387 |
| 74 | Lethargy (HP:0001254) | 2.78291080 |
| 75 | Papilloma (HP:0012740) | 2.77011549 |
| 76 | Verrucae (HP:0200043) | 2.77011549 |
| 77 | Abnormality of glycine metabolism (HP:0010895) | 2.77006520 |
| 78 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.77006520 |
| 79 | Focal motor seizures (HP:0011153) | 2.73872744 |
| 80 | Abnormality of the common coagulation pathway (HP:0010990) | 2.73359534 |
| 81 | Increased CSF lactate (HP:0002490) | 2.71309151 |
| 82 | B lymphocytopenia (HP:0010976) | 2.70632256 |
| 83 | Hypoglycemic coma (HP:0001325) | 2.70254314 |
| 84 | Pulmonary infiltrates (HP:0002113) | 2.69629247 |
| 85 | Abnormality of the intrinsic pathway (HP:0010989) | 2.68481751 |
| 86 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.67602344 |
| 87 | Hyperbilirubinemia (HP:0002904) | 2.67577540 |
| 88 | Encephalitis (HP:0002383) | 2.67411480 |
| 89 | Skin rash (HP:0000988) | 2.67250494 |
| 90 | Epidermoid cyst (HP:0200040) | 2.67008102 |
| 91 | Abnormal gallbladder morphology (HP:0012437) | 2.65685172 |
| 92 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.64871137 |
| 93 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.63995919 |
| 94 | Fat malabsorption (HP:0002630) | 2.58859208 |
| 95 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.58849656 |
| 96 | Leukopenia (HP:0001882) | 2.58390823 |
| 97 | Petechiae (HP:0000967) | 2.58333904 |
| 98 | Hypertensive crisis (HP:0100735) | 2.56828982 |
| 99 | Hypothermia (HP:0002045) | 2.56671086 |
| 100 | Xerostomia (HP:0000217) | 2.54571389 |
| 101 | Lipid accumulation in hepatocytes (HP:0006561) | 2.53594210 |
| 102 | Pheochromocytoma (HP:0002666) | 2.52406564 |
| 103 | Metabolic acidosis (HP:0001942) | 2.51984090 |
| 104 | Purpura (HP:0000979) | 2.51221207 |
| 105 | Lymphoma (HP:0002665) | 2.45450440 |
| 106 | Abnormality of the prostate (HP:0008775) | 2.43830157 |
| 107 | Increased hepatocellular lipid droplets (HP:0006565) | 2.43345773 |
| 108 | Irritability (HP:0000737) | 2.43285439 |
| 109 | Dry hair (HP:0011359) | 2.43236673 |
| 110 | Neurofibrillary tangles (HP:0002185) | 2.42503850 |
| 111 | Abnormality of B cell number (HP:0010975) | 2.41448597 |
| 112 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.40569644 |
| 113 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.40474408 |
| 114 | Optic neuritis (HP:0100653) | 2.39203106 |
| 115 | Retrobulbar optic neuritis (HP:0100654) | 2.39203106 |
| 116 | Arthralgia (HP:0002829) | 2.39064949 |
| 117 | Sensory axonal neuropathy (HP:0003390) | 2.39012869 |
| 118 | Hyperglycinuria (HP:0003108) | 2.38592754 |
| 119 | Hypochromic microcytic anemia (HP:0004840) | 2.38302802 |
| 120 | Sepsis (HP:0100806) | 2.34352751 |
| 121 | Abnormality of glycolipid metabolism (HP:0010969) | 2.33656188 |
| 122 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.33656188 |
| 123 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.33656188 |
| 124 | Skin nodule (HP:0200036) | 2.33489023 |
| 125 | Dicarboxylic aciduria (HP:0003215) | 2.31241121 |
| 126 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.31241121 |
| 127 | Basal cell carcinoma (HP:0002671) | 2.31118035 |
| 128 | Spontaneous hematomas (HP:0007420) | 2.30295974 |
| 129 | Neuroendocrine neoplasm (HP:0100634) | 2.30276041 |
| 130 | Hypoalphalipoproteinemia (HP:0003233) | 2.30096822 |
| 131 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.29777125 |
| 132 | Cholelithiasis (HP:0001081) | 2.29701398 |
| 133 | Abnormality of T cells (HP:0002843) | 2.28995242 |
| 134 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.28692080 |
| 135 | Squamous cell carcinoma (HP:0002860) | 2.28137351 |
| 136 | Increased intramyocellular lipid droplets (HP:0012240) | 2.27444521 |
| 137 | Cerebral inclusion bodies (HP:0100314) | 2.27399100 |
| 138 | Lactic acidosis (HP:0003128) | 2.26297959 |
| 139 | Spastic paraparesis (HP:0002313) | 2.25422116 |
| 140 | Myositis (HP:0100614) | 2.24824446 |
| 141 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.21926288 |
| 142 | Vomiting (HP:0002013) | 2.21866219 |
| 143 | Brushfield spots (HP:0001088) | 2.20457244 |
| 144 | Hypergammaglobulinemia (HP:0010702) | 2.19748490 |
| 145 | Leukodystrophy (HP:0002415) | 2.19169950 |
| 146 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.18939146 |
| 147 | Status epilepticus (HP:0002133) | 2.18794154 |
| 148 | Premature loss of primary teeth (HP:0006323) | 2.17467078 |
| 149 | Abnormality of the pleura (HP:0002103) | 2.17375358 |
| 150 | Delayed CNS myelination (HP:0002188) | 2.17074865 |
| 151 | Late onset (HP:0003584) | 2.16396742 |
| 152 | Autoimmune thrombocytopenia (HP:0001973) | 2.16081312 |
| 153 | Orchitis (HP:0100796) | 2.15652262 |
| 154 | Viral hepatitis (HP:0006562) | 2.14931288 |
| 155 | Recurrent otitis media (HP:0000403) | 2.14345298 |
| 156 | Acrocyanosis (HP:0001063) | 2.13074478 |
| 157 | Increased muscle lipid content (HP:0009058) | 2.12927378 |
| 158 | Hypercholesterolemia (HP:0003124) | 2.10861813 |
| 159 | Chronic otitis media (HP:0000389) | 2.10536092 |
| 160 | Abnormality of serum amino acid levels (HP:0003112) | 2.09346193 |
| 161 | Methylmalonic acidemia (HP:0002912) | 2.09246822 |
| 162 | Amyloidosis (HP:0011034) | 2.07269906 |
| 163 | Ragged-red muscle fibers (HP:0003200) | 2.05619314 |
| 164 | Progressive external ophthalmoplegia (HP:0000590) | 2.05325488 |
| 165 | Bronchitis (HP:0012387) | 2.04602492 |
| 166 | Abnormality of the gallbladder (HP:0005264) | 2.03908377 |
| 167 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.03159635 |
| 168 | Abnormality of complement system (HP:0005339) | 2.00567968 |
| 169 | Autoimmune hemolytic anemia (HP:0001890) | 1.99750301 |
| 170 | Focal seizures (HP:0007359) | 1.99318720 |
| 171 | Hepatitis (HP:0012115) | 1.98654096 |
| 172 | Joint swelling (HP:0001386) | 1.98155573 |
| 173 | 3-Methylglutaconic aciduria (HP:0003535) | 1.98138647 |
| 174 | Cerebral hemorrhage (HP:0001342) | 1.97589578 |
| 175 | Vacuolated lymphocytes (HP:0001922) | 1.97204384 |
| 176 | Delusions (HP:0000746) | 1.95741803 |
| 177 | Dialeptic seizures (HP:0011146) | 1.95019846 |
| 178 | Epistaxis (HP:0000421) | 1.94587282 |
| 179 | Opisthotonus (HP:0002179) | 1.93676477 |
| 180 | Skin ulcer (HP:0200042) | 1.93638447 |
| 181 | Neonatal onset (HP:0003623) | 1.93123436 |
| 182 | Increased serum lactate (HP:0002151) | 1.92923531 |
| 183 | Methylmalonic aciduria (HP:0012120) | 1.92843159 |
| 184 | Hemoptysis (HP:0002105) | 1.92320168 |
| 185 | Gout (HP:0001997) | 1.92173920 |
| 186 | Chest pain (HP:0100749) | 1.91858394 |
| 187 | Respiratory failure (HP:0002878) | 1.89998682 |
| 188 | Acute hepatic failure (HP:0006554) | 1.89767604 |
| 189 | Fatigue (HP:0012378) | 1.89496267 |
| 190 | Pulmonary embolism (HP:0002204) | 1.88255800 |
| 191 | Neutropenia (HP:0001875) | 1.86147089 |
| 192 | Increased serum ferritin (HP:0003281) | 1.84796306 |
| 193 | Dysostosis multiplex (HP:0000943) | 1.83300816 |
| 194 | Pulmonary fibrosis (HP:0002206) | 1.82805298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.45862605 |
| 2 | CASK | 4.40187670 |
| 3 | BCKDK | 3.43822515 |
| 4 | GRK5 | 3.42400415 |
| 5 | NTRK3 | 3.07564168 |
| 6 | MAP3K14 | 2.98817934 |
| 7 | MAP2K4 | 2.87883006 |
| 8 | NTRK1 | 2.69639300 |
| 9 | EIF2AK3 | 2.68417236 |
| 10 | ARAF | 2.61290413 |
| 11 | SMG1 | 2.59734039 |
| 12 | PRPF4B | 2.58874328 |
| 13 | TBK1 | 2.47794646 |
| 14 | IRAK4 | 2.47138602 |
| 15 | EPHA4 | 2.45270663 |
| 16 | BLK | 2.38472988 |
| 17 | MAP3K4 | 2.30781273 |
| 18 | VRK1 | 2.29865650 |
| 19 | ADRBK2 | 2.24699795 |
| 20 | STK16 | 2.20475738 |
| 21 | GRK6 | 2.16663604 |
| 22 | MAP3K13 | 2.14726856 |
| 23 | MAP2K7 | 2.09964351 |
| 24 | SYK | 2.05710858 |
| 25 | TLK1 | 2.05624229 |
| 26 | TYK2 | 2.00296485 |
| 27 | NEK9 | 2.00054188 |
| 28 | SIK2 | 1.91947945 |
| 29 | IKBKE | 1.84538234 |
| 30 | IKBKB | 1.81708557 |
| 31 | MARK1 | 1.78320666 |
| 32 | MAP3K12 | 1.70047370 |
| 33 | NME1 | 1.69515931 |
| 34 | GRK7 | 1.63072099 |
| 35 | KIT | 1.59206083 |
| 36 | DAPK2 | 1.57589859 |
| 37 | BTK | 1.56317690 |
| 38 | EEF2K | 1.51419801 |
| 39 | ZAK | 1.50742761 |
| 40 | ERN1 | 1.49803897 |
| 41 | CSNK1G3 | 1.41116756 |
| 42 | CDK12 | 1.40170026 |
| 43 | RIPK4 | 1.40034828 |
| 44 | LYN | 1.38938851 |
| 45 | TNIK | 1.37318040 |
| 46 | INSRR | 1.36342406 |
| 47 | JAK1 | 1.35330207 |
| 48 | UHMK1 | 1.34318816 |
| 49 | JAK3 | 1.32560250 |
| 50 | TESK2 | 1.25718675 |
| 51 | STK39 | 1.25617766 |
| 52 | TAOK2 | 1.25511988 |
| 53 | CSNK1G2 | 1.25120372 |
| 54 | TAOK3 | 1.19470342 |
| 55 | DYRK2 | 1.19223796 |
| 56 | CAMK2B | 1.16905207 |
| 57 | CDK19 | 1.15950876 |
| 58 | RPS6KA5 | 1.15608882 |
| 59 | IRAK3 | 1.14717361 |
| 60 | MINK1 | 1.11057287 |
| 61 | PRKCG | 1.11048573 |
| 62 | TRIB3 | 1.10607362 |
| 63 | BRAF | 1.09654352 |
| 64 | ADRBK1 | 1.08190660 |
| 65 | MUSK | 1.06868102 |
| 66 | OXSR1 | 1.04705686 |
| 67 | CSK | 1.04561885 |
| 68 | SIK3 | 1.02740520 |
| 69 | MAP3K10 | 1.02709627 |
| 70 | BMPR2 | 1.02628232 |
| 71 | PBK | 1.00716573 |
| 72 | CAMK2G | 0.96179817 |
| 73 | CDK4 | 0.96062464 |
| 74 | CAMK2A | 0.92948301 |
| 75 | CHUK | 0.92340104 |
| 76 | MET | 0.90344492 |
| 77 | PASK | 0.90075199 |
| 78 | SIK1 | 0.89362009 |
| 79 | CSNK1G1 | 0.88686413 |
| 80 | DAPK1 | 0.87854511 |
| 81 | PINK1 | 0.85595531 |
| 82 | BUB1 | 0.85039183 |
| 83 | CDC42BPA | 0.84673199 |
| 84 | MAPK7 | 0.83684727 |
| 85 | ERBB4 | 0.83552920 |
| 86 | DDR2 | 0.82047810 |
| 87 | FGFR4 | 0.81810948 |
| 88 | ABL2 | 0.81073687 |
| 89 | MAP2K3 | 0.80924523 |
| 90 | PIM1 | 0.80245346 |
| 91 | FES | 0.78908377 |
| 92 | CDK5 | 0.78585861 |
| 93 | MAP3K8 | 0.77503774 |
| 94 | MAPK13 | 0.77488027 |
| 95 | FGR | 0.76929655 |
| 96 | MAP3K9 | 0.76864036 |
| 97 | PLK2 | 0.76503299 |
| 98 | MAPK12 | 0.75733822 |
| 99 | MAP3K1 | 0.74473846 |
| 100 | SGK494 | 0.74148842 |
| 101 | SGK223 | 0.74148842 |
| 102 | KSR2 | 0.74117768 |
| 103 | PKN1 | 0.71443617 |
| 104 | MARK3 | 0.71124971 |
| 105 | MAPK4 | 0.71035435 |
| 106 | LCK | 0.70914714 |
| 107 | LIMK1 | 0.70255538 |
| 108 | HCK | 0.69941778 |
| 109 | JAK2 | 0.69805543 |
| 110 | VRK2 | 0.69223063 |
| 111 | CAMK2D | 0.68544416 |
| 112 | MAP3K6 | 0.67956758 |
| 113 | AURKA | 0.66343364 |
| 114 | CAMKK2 | 0.66009548 |
| 115 | CCNB1 | 0.64260884 |
| 116 | BCR | 0.63256402 |
| 117 | KDR | 0.60427589 |
| 118 | CSNK1A1L | 0.57929624 |
| 119 | MAP2K1 | 0.57337975 |
| 120 | RPS6KB2 | 0.56856719 |
| 121 | MAP3K2 | 0.56527316 |
| 122 | STK10 | 0.56516072 |
| 123 | PDK1 | 0.55628253 |
| 124 | MAPKAPK5 | 0.54721213 |
| 125 | AKT3 | 0.54072081 |
| 126 | CDK14 | 0.52902540 |
| 127 | PRKACA | 0.51455794 |
| 128 | WNK4 | 0.51327288 |
| 129 | PRKCH | 0.50538896 |
| 130 | NME2 | 0.50472871 |
| 131 | CSF1R | 0.50080803 |
| 132 | HIPK2 | 0.50036537 |
| 133 | CDK9 | 0.49633220 |
| 134 | PRKCE | 0.48724043 |
| 135 | PRKCQ | 0.47660538 |
| 136 | TAF1 | 0.47152359 |
| 137 | FGFR3 | 0.46831966 |
| 138 | MAP3K11 | 0.46820631 |
| 139 | ICK | 0.45297382 |
| 140 | ITK | 0.45125292 |
| 141 | STK24 | 0.44163465 |
| 142 | ALK | 0.43833948 |
| 143 | PTK2B | 0.43701950 |
| 144 | CDK18 | 0.43528139 |
| 145 | TEC | 0.42958223 |
| 146 | CDK15 | 0.42723963 |
| 147 | CDC7 | 0.42704596 |
| 148 | RPS6KA2 | 0.41386681 |
| 149 | PRKACG | 0.41062549 |
| 150 | PIM2 | 0.40326339 |
| 151 | STK4 | 0.39896671 |
| 152 | WNK1 | 0.38540061 |
| 153 | GRK1 | 0.36844119 |
| 154 | PAK6 | 0.36487922 |
| 155 | MST1R | 0.35341859 |
| 156 | MELK | 0.34666267 |
| 157 | MAPKAPK3 | 0.34573005 |
| 158 | MATK | 0.34373834 |
| 159 | DAPK3 | 0.34293220 |
| 160 | PDPK1 | 0.34035632 |
| 161 | CDK11A | 0.33938746 |
| 162 | CHEK2 | 0.33024311 |
| 163 | TNK2 | 0.32893488 |
| 164 | MAPK11 | 0.31624744 |
| 165 | PRKCD | 0.30629994 |
| 166 | RPS6KL1 | 0.29287256 |
| 167 | RPS6KC1 | 0.29287256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.42230489 |
| 2 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 4.41079273 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 4.33823330 |
| 4 | Asthma_Homo sapiens_hsa05310 | 4.14642300 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.88777155 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.69552039 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.67229918 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.52948084 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.20931347 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.80050024 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.65867667 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.57841015 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 2.52549964 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.52459802 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.48309103 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 2.43145436 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.42747032 |
| 18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.42663761 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.39948592 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.37779364 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.27354933 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.26061694 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.24621743 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.24097659 |
| 25 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.23035027 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17765046 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 2.06445922 |
| 28 | Alcoholism_Homo sapiens_hsa05034 | 2.03884852 |
| 29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.97637480 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.94272193 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.93648562 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.91510849 |
| 33 | Parkinsons disease_Homo sapiens_hsa05012 | 1.85479718 |
| 34 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.84025511 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.82409762 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.80878636 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.80256695 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.77960620 |
| 39 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.71594679 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.70581411 |
| 41 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.69374122 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.66892418 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 1.66511289 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.63547654 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.63021666 |
| 46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.60476524 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.57379459 |
| 48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.55553833 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.52736122 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50758682 |
| 51 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.50151908 |
| 52 | Alzheimers disease_Homo sapiens_hsa05010 | 1.49936611 |
| 53 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.49583761 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.49271684 |
| 55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48291631 |
| 56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.46465283 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.45915090 |
| 58 | Tuberculosis_Homo sapiens_hsa05152 | 1.42553131 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40344586 |
| 60 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.37898428 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.35404119 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.34968523 |
| 63 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.31663660 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.31538605 |
| 65 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.31408596 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.28084866 |
| 67 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.27664727 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.27585021 |
| 69 | Measles_Homo sapiens_hsa05162 | 1.26540425 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22774108 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 1.20558163 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.17343511 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14296782 |
| 74 | Protein export_Homo sapiens_hsa03060 | 1.13772416 |
| 75 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.13248650 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.12045628 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.08710636 |
| 78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08495226 |
| 79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.07739869 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 1.05589915 |
| 81 | Retinol metabolism_Homo sapiens_hsa00830 | 1.05285611 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04380552 |
| 83 | Huntingtons disease_Homo sapiens_hsa05016 | 1.02293014 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.97706844 |
| 85 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.97388048 |
| 86 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.92935134 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.86967821 |
| 88 | Hepatitis B_Homo sapiens_hsa05161 | 0.83000549 |
| 89 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82901347 |
| 90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81552630 |
| 91 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78304439 |
| 92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.78089633 |
| 93 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76902243 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.76380844 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75083196 |
| 96 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.72736999 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72435580 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.70445761 |
| 99 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.69390571 |
| 100 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68282903 |
| 101 | ABC transporters_Homo sapiens_hsa02010 | 0.67166320 |
| 102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66371088 |
| 103 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.65611611 |
| 104 | GABAergic synapse_Homo sapiens_hsa04727 | 0.64178348 |
| 105 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62334552 |
| 106 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62278095 |
| 107 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61790872 |
| 108 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59420638 |
| 109 | Pertussis_Homo sapiens_hsa05133 | 0.58821364 |
| 110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57780528 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | 0.57526453 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54134698 |
| 113 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.53280626 |
| 114 | Shigellosis_Homo sapiens_hsa05131 | 0.52965112 |
| 115 | Lysosome_Homo sapiens_hsa04142 | 0.52938589 |
| 116 | Malaria_Homo sapiens_hsa05144 | 0.52796568 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52638050 |
| 118 | Legionellosis_Homo sapiens_hsa05134 | 0.52538452 |
| 119 | DNA replication_Homo sapiens_hsa03030 | 0.50974392 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50729678 |
| 121 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.50562179 |
| 122 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49981928 |
| 123 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49787821 |
| 124 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.49649571 |
| 125 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49501156 |
| 126 | Nicotine addiction_Homo sapiens_hsa05033 | 0.49028032 |
| 127 | Proteasome_Homo sapiens_hsa03050 | 0.48708489 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.47273765 |
| 129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47029634 |
| 130 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.46418425 |
| 131 | Base excision repair_Homo sapiens_hsa03410 | 0.46336049 |
| 132 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46108186 |
| 133 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45972615 |
| 134 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44386902 |
| 135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44369836 |
| 136 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42145895 |
| 137 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.42068996 |
| 138 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.41892503 |
| 139 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.41022960 |
| 140 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38936744 |
| 141 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.36913653 |
| 142 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33959911 |
| 143 | Cocaine addiction_Homo sapiens_hsa05030 | 0.33193102 |
| 144 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31539890 |
| 145 | Salmonella infection_Homo sapiens_hsa05132 | 0.30963904 |
| 146 | Taste transduction_Homo sapiens_hsa04742 | 0.29417986 |
| 147 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29367922 |
| 148 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29012952 |
| 149 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.28996043 |
| 150 | Long-term potentiation_Homo sapiens_hsa04720 | 0.26573031 |
| 151 | Bladder cancer_Homo sapiens_hsa05219 | 0.25998285 |
| 152 | Insulin secretion_Homo sapiens_hsa04911 | 0.25551298 |
| 153 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.24144054 |
| 154 | Morphine addiction_Homo sapiens_hsa05032 | 0.23096834 |
| 155 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.21994551 |
| 156 | Circadian entrainment_Homo sapiens_hsa04713 | 0.21046158 |
| 157 | Spliceosome_Homo sapiens_hsa03040 | 0.20812330 |
| 158 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.20382997 |
| 159 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20031406 |
| 160 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.19792351 |
| 161 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.18783390 |
| 162 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.18235897 |
| 163 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.17865911 |
| 164 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.17726587 |
| 165 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.17105358 |
| 166 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.17082644 |
| 167 | Ribosome_Homo sapiens_hsa03010 | 0.15642492 |
| 168 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.15220135 |
| 169 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.13123884 |
| 170 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.08790160 |
| 171 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.08439831 |
| 172 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.06628916 |
| 173 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.04975981 |
| 174 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.04792722 |
| 175 | Platelet activation_Homo sapiens_hsa04611 | 0.04468401 |

